Literature DB >> 12365308

Needle aspiration for suppurative cervical lymphadenitis.

Francis Serour1, Arkadi Gorenstein, Eli Somekh.   

Abstract

In a 10-year prospective study, we used needle aspiration as the treatment of suppurative cervical lymphadenitis that required drainage procedure in 35 consecutive children aged 4 months to 13 years (mean 2.2 years). Twenty-seven patients underwent 1 puncture, 7 patients had 2 punctures, and 1 had 3 punctures. There were no major complications. Patients were followed up for 2-6 months. None required an open drainage of the cervical abscess. There was complete regression of the nodes in all patients within 21 days, with no relapse or scar formation. Needle aspiration seems to be an effective and safe treatment of suppurative cervical lymphadenitis that may avoid open drainage.

Entities:  

Mesh:

Year:  2002        PMID: 12365308     DOI: 10.1177/000992280204100703

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  Needle aspiration as therapeutic management for suppurative cervical lymphadenitis in children.

Authors:  Mee Young Baek; Kyung Hee Park; Ju Hee We; Su Eun Park
Journal:  Korean J Pediatr       Date:  2010-08-31

2.  Suppurative lymphadenitis.

Authors:  Iain P Fraser
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

Review 3.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.